Cargando…

The Role of Immune Checkpoint Receptors in Regulating Immune Reactivity in Lupus

Immune checkpoint receptors with co-stimulatory and co-inhibitory signals are important modulators for the immune system. However, unrestricted co-stimulation and/or inadequate co-inhibition may cause breakdown of self-tolerance, leading to autoimmunity. Systemic lupus erythematosus (SLE) is a compl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Kun-Lin, Wu, Ming-Ying, Wang, Chi-Hui, Wang, Chuang-Wei, Hung, Shuen-Iu, Chung, Wen-Hung, Chen, Chun-Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829486/ https://www.ncbi.nlm.nih.gov/pubmed/31597242 http://dx.doi.org/10.3390/cells8101213

Ejemplares similares

Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review
por: Chen, Chun-Bing, et al.
Publicado: (2023)

Digging Up the Human Genome: Current Progress in Deciphering Adverse Drug Reactions
por: Su, Shih-Chi, et al.
Publicado: (2014)

Immediate Hypersensitivity Reactions Induced by COVID-19 Vaccines: Current Trends, Potential Mechanisms and Prevention Strategies
por: Hung, Shuen-Iu, et al.
Publicado: (2022)

Therapeutic Vaccines Targeting Neoantigens to Induce T-Cell Immunity against Cancers
por: Pao, Shih-Cheng, et al.
Publicado: (2022)

Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators
por: Chu, Mu-Tzu, et al.
Publicado: (2023)

An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity
por: Chen, Chun-Bing, et al.
Publicado: (2018)

Erratum to “An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity”
por: Chen, Chun-Bing, et al.
Publicado: (2019)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Immune checkpoint receptors in regulating immune reactivity in rheumatic disease
por: Ceeraz, Sabrina, et al.
Publicado: (2014)

Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs
por: Wung, Chih-Hsuan, et al.
Publicado: (2023)

The Roles of Immunoregulatory Networks in Severe Drug Hypersensitivity
por: Hsu, Yun-Shiuan Olivia, et al.
Publicado: (2021)

Use of in vitro tests to assess the causative drugs for NSAIDs-induced type I hypersensitivity
por: Chang, Wan-Chun, et al.
Publicado: (2014)

Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck Cancer
por: Chung, Chih‐Hung, et al.
Publicado: (2023)

Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation
por: Su, Shih-Chi, et al.
Publicado: (2016)

NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression
por: Tsao, Yen-Po, et al.
Publicado: (2023)

NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression
por: Tsao, Yen-Po, et al.
Publicado: (2023)

The role of genetic variants in human longevity
por: Chung, Wen-Hung, et al.
Publicado: (2010)

Combination Biomarker of Immune Checkpoints Predict Prognosis of Urothelial Carcinoma
por: Tsai, Chung-Ying, et al.
Publicado: (2021)

Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report
por: Lau, Kin-Sang, et al.
Publicado: (2021)

Immune checkpoint receptors: homeostatic regulators of immunity
por: Riva, Antonio, et al.
Publicado: (2018)

Activation of phagocytosis by immune checkpoint blockade
por: Li, Chia-Wei, et al.
Publicado: (2018)

Different immune contextures underlie tumor site‐specific responses to immune checkpoint blockade in esophageal cancer
por: Guo, Jhe‐Cyuan, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor, Nivolumab, Combined with Chemotherapy Improved the Survival of Unresectable Advanced and Metastatic Esophageal Squamous Cell Carcinoma: A Real-World Experience
por: Kao, Ming-Wei, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor-Induced Hemorrhagic Gastritis
por: Mathialagan, Karthik, et al.
Publicado: (2023)

Immune Checkpoint Receptors Signaling in T Cells
por: Baldanzi, Gianluca
Publicado: (2022)

Response Prediction in Immune Checkpoint Inhibitor Immunotherapy for Advanced Hepatocellular Carcinoma
por: Hung, Hao-Chien, et al.
Publicado: (2021)

Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components
por: Hsu, Sheng-Kai, et al.
Publicado: (2022)

Immune checkpoint inhibitors
por: Hui, Enfu
Publicado: (2019)

Reduced FEV(1) as Prognostic Factors in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors
por: Shen, Yi-Luen, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor-related Endocrinopathies
por: Lu, Difei, et al.
Publicado: (2022)

A Comprehensive Review of US FDA-Approved Immune Checkpoint Inhibitors in Urothelial Carcinoma
por: Hsu, Fu-Shun, et al.
Publicado: (2017)

Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma
por: Lee, Pei-Chang, et al.
Publicado: (2020)

Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab
por: Lin, Jamie S, et al.
Publicado: (2020)

Reactivation of dormant anti-tumor immunity – a clinical perspective of therapeutic immune checkpoint modulation
por: Greil, Richard, et al.
Publicado: (2017)

The Extended Surgical Concepts for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors
por: Hsu, Hsiao-Mei, et al.
Publicado: (2023)

Expression of the immune checkpoint receptor TIGIT in seminoma
por: Hinsch, Andrea, et al.
Publicado: (2019)

Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens
por: Pan, Ren-You, et al.
Publicado: (2018)

An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma
por: Shen, Ying-Chun, et al.
Publicado: (2021)

Stromal C-type lectin receptor COLEC12 integrates H. pylori, PGE2-EP2/4 axis and innate immunity in gastric diseases
por: Chang, Lin-Li, et al.
Publicado: (2018)

Ablative Radiotherapy Reprograms the Tumor Microenvironment of a Pancreatic Tumor in Favoring the Immune Checkpoint Blockade Therapy
por: Lee, Yu-Hung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5jcd6c8297ernm75m1ibpp778k